Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Dai Ming, Fan"'
Autor:
Dai-Ming Fan
Publikováno v:
World Journal of Traditional Chinese Medicine, Vol 10, Iss 3, Pp 271-273 (2024)
Holistic integrative medicine (HIM) has been officially propounded since 2012. Its theoretical system has continuously been improved, and its practical methods have become increasingly diverse, becoming an inevitable choice and path for medical devel
Externí odkaz:
https://doaj.org/article/21170c802600405781b091bf28b6d3ca
Publikováno v:
Therapeutics and Clinical Risk Management
Objective The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). Setting A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. Th
Autor:
Zhe-Xuan Wang, En-Xin Wang, Wei Bai, Dong-Dong Xia, Wei Mu, Jing Li, Qiao-Yi Yang, Ming Huang, Guo-Hui Xu, Jun-Hui Sun, Hai-Liang Li, Hui Zhao, Jian-Bing Wu, Shu-Fa Yang, Jia-Ping Li, Zi-Xiang Li, Chun-Qing Zhang, Xiao-Li Zhu, Yan-Bo Zheng, Qiu-He Wang, Jie Yuan, Xiao-Mei Li, Jing Niu, Zhan-Xin Yin, Jie-Lai Xia, Dai-Ming Fan, Guo-Hong Han, on behalf of China HCC-TACE Study Group
Publikováno v:
World Journal of Gastroenterology
BACKGROUND The treatment outcome of transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) varies greatly due to the clinical heterogeneity of the patients. Therefore, several prognostic systems have been proposed for r
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e52940 (2013)
AimsThe aim of this study was to investigate the antimetastatic effect of multiple antigenic polypeptide (MAP) vaccine based on B-cell epitopes of heparanase (HPSE) on human hepatocellular carcinoma (HCC) in vivo.MethodsThe antiserum against B-cell e
Externí odkaz:
https://doaj.org/article/c2dd851fb0954495a687258ef7a0b23f
Autor:
Yi Chu, Dai Ming Fan, Bing Xu, Xiaowei Li, Yujie Zhang, Wei Jie Wang, Jie Liang, Ren Mao, Di Chen, Ming Zuo Jiang
Publikováno v:
Journal of Digestive Diseases. 19:74-83
OBJECTIVE To explore the relationship between gasdermin D (GSDMD) and gastric cancer (GC) cell proliferation, and to determine whether the downregulated expression of GSDMD contributed to the tumorigenesis and proliferation of GC cells. METHODS GSDMD
Publikováno v:
Journal of the Formosan Medical Association, Vol 112, Iss 5, Pp 235-236 (2013)
Externí odkaz:
https://doaj.org/article/2ea8a29a86c242228fa73d45ce4b4f0d
Publikováno v:
Molecular & Clinical Oncology. Nov/Dec2015, Vol. 3 Issue 6, p1199-1202. 4p.
Autor:
Wei Jie, Wang, Di, Chen, Ming Zuo, Jiang, Bing, Xu, Xiao Wei, Li, Yi, Chu, Yu Jie, Zhang, Ren, Mao, Jie, Liang, Dai Ming, Fan
Publikováno v:
Journal of digestive diseases. 19(2)
To explore the relationship between gasdermin D (GSDMD) and gastric cancer (GC) cell proliferation, and to determine whether the downregulated expression of GSDMD contributed to the tumorigenesis and proliferation of GC cells.GSDMD expressions in GC
Autor:
Yiqi Du, Zhao Shen Li, Xiao Hua Hou, Li Ya Zhou, Xiao Yan Zhao, Bo Jiang, Dongfeng Chen, Hua Hong Wang, Dai Ming Fan, Weng Fei Yu, Duo Wu Zou, Wei Hong Sha, Nong Hua Lu, Zhen Dong Jin, Min Hu Chen, Xiaofeng Yu, Xiao Jun Huang, Yao Zong Yuan, Rong Quan Wang, Jiang Bin Wang, Shu Tian Zhang, De An Tian, Li Ping Ye, Feng Ji, Dong Wang, Ji Yao Wang, Jian Wei Zheng, Yu Bai, Kai Chun Wu, Yi Jiang, Xianbao Zhan
Publikováno v:
Journal of Digestive Diseases. 15:5-11
ObjectiveWe aimed to describe the clinical picture, management and outcomes of Chinese patients with peptic ulcer bleeding (PUB), especially in those with high risks. MethodsA multicenter endoscopic survey was conducted. All consecutive patients with
Autor:
Rui Jun Li, Jie Lai Xia, Zhan Xin Yin, Wei Bai, Dai Ming Fan, Xingshun Qi, Yan Zhao, Chuang Ye He, G. Han, Yongji Wang, Kai Chun Wu
Publikováno v:
Journal of Digestive Diseases. 14:181-190
Objective This prospective non-randomized controlled trial aimed to compare the efficacy of sorafenib in combination with transarterial chemoembolization (TACE) vs TACE alone for the treatment of patients with unresectable intermediate or advanced he